Glenmark Pharmaceuticals has signed a strategic development and licensing agreement with Celon Pharma, a Poland-based company, for the development and marketing of its generic version of Seretide Accuhaler in Europe targeting the treatment of lung diseases. GSK's Seretide Accuhaler product,...
Keywords: Celon Pharma, Celon Pharma, Glenmark, Seretide Accuhaler
Read More